FERMENTA BIOTECH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 163.4 INR | +1.02% |
|
-4.74% | -0.56% |
| 02-15 | Fermenta Biotech Sells Premises in Thane, India for INR136 Million | MT |
| 02-12 | Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6,552 | 7,550 | 6,261 | 7,220 | 5,934 | 3,085 |
| Enterprise Value (EV) 1 | 7,948 | 8,760 | 8,366 | 9,179 | 8,068 | 4,682 |
| P/E ratio | 18.4 x | 6.84 x | 10.4 x | 16 x | 38.6 x | -5.99 x |
| Yield | 0.18% | 0.15% | 2.35% | 1% | 0.61% | 1.17% |
| Capitalization / Revenue | 2.16 x | 1.87 x | 2.14 x | 1.91 x | 1.49 x | 0.88 x |
| EV / Revenue | 2.63 x | 2.16 x | 2.86 x | 2.43 x | 2.02 x | 1.34 x |
| EV / EBITDA | 8.33 x | 5.81 x | 13.1 x | 11.5 x | 13.6 x | 28.4 x |
| EV / FCF | 49.6 x | 107 x | -8.59 x | 82.8 x | -49.8 x | 8.67 x |
| FCF Yield | 2.02% | 0.94% | -11.6% | 1.21% | -2.01% | 11.5% |
| Price to Book | 5.18 x | 3.25 x | 1.98 x | 2 x | 1.59 x | 0.98 x |
| Nbr of stocks (in thousands) | 27,518 | 27,518 | 29,431 | 28,847 | 28,847 | 28,847 |
| Reference price 2 | 238.1 | 274.4 | 212.8 | 250.3 | 205.7 | 107.0 |
| Announcement Date | 18-09-05 | 19-06-13 | 20-09-25 | 21-08-10 | 22-07-16 | 23-09-06 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3,027 | 4,047 | 2,929 | 3,773 | 3,985 | 3,499 |
| EBITDA 1 | 954.4 | 1,509 | 636.4 | 796.7 | 591.7 | 164.7 |
| EBIT 1 | 835.2 | 1,394 | 508.3 | 615.2 | 359.8 | -99.94 |
| Operating Margin | 27.59% | 34.46% | 17.35% | 16.3% | 9.03% | -2.86% |
| Earnings before Tax (EBT) 1 | 694.5 | 1,283 | 434.2 | 516.3 | 269.4 | -518.7 |
| Net income 1 | 356.9 | 1,104 | 595.3 | 455.1 | 154.5 | -515 |
| Net margin | 11.79% | 27.27% | 20.32% | 12.06% | 3.88% | -14.72% |
| EPS 2 | 12.97 | 40.10 | 20.53 | 15.69 | 5.330 | -17.85 |
| Free Cash Flow 1 | 160.2 | 81.92 | -973.7 | 110.8 | -162.1 | 540 |
| FCF margin | 5.29% | 2.02% | -33.24% | 2.94% | -4.07% | 15.43% |
| FCF Conversion (EBITDA) | 16.78% | 5.43% | - | 13.91% | - | 327.8% |
| FCF Conversion (Net income) | 44.88% | 7.42% | - | 24.35% | - | - |
| Dividend per Share 2 | 0.4167 | 0.4167 | 5.000 | 2.500 | 1.250 | 1.250 |
| Announcement Date | 18-09-05 | 19-06-13 | 20-09-25 | 21-08-10 | 22-07-16 | 23-09-06 |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|
| Net sales 1 | - | 998.5 | 928.6 | 961.6 |
| EBITDA 1 | - | 157 | 22.08 | 177.7 |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income 1 | 113.1 | 44.99 | -80.43 | 76.79 |
| Net margin | - | 4.51% | -8.66% | 7.99% |
| EPS | 3.920 | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 21-08-13 | 21-11-12 | 22-02-14 | 22-05-30 |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,396 | 1,211 | 2,105 | 1,958 | 2,134 | 1,597 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.463 x | 0.8024 x | 3.307 x | 2.458 x | 3.606 x | 9.692 x |
| Free Cash Flow 1 | 160 | 81.9 | -974 | 111 | -162 | 540 |
| ROE (net income / shareholders' equity) | 31.1% | 60.9% | 21.3% | 12.7% | 4.12% | -15.7% |
| ROA (Net income/ Total Assets) | 15% | 18.6% | 5.45% | 5.91% | 3.23% | -0.93% |
| Assets 1 | 2,374 | 5,949 | 10,913 | 7,698 | 4,788 | 55,356 |
| Book Value Per Share 2 | 45.90 | 84.50 | 107.0 | 125.0 | 129.0 | 109.0 |
| Cash Flow per Share 2 | 11.80 | 14.80 | 2.600 | 5.820 | 4.530 | 12.20 |
| Capex 1 | 195 | 358 | 685 | 553 | 371 | 405 |
| Capex / Sales | 6.45% | 8.84% | 23.37% | 14.65% | 9.32% | 11.57% |
| Announcement Date | 18-09-05 | 19-06-13 | 20-09-25 | 21-08-10 | 22-07-16 | 23-09-06 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -0.56% | 57.11M | |
| -2.62% | 88.91B | |
| +2.76% | 41.25B | |
| -13.92% | 31.99B | |
| +50.51% | 24.73B | |
| -15.25% | 15.54B | |
| -39.93% | 12.07B | |
| -9.08% | 12.05B | |
| -14.80% | 12.02B | |
| +6.22% | 8.84B |
- Stock Market
- Equities
- FERMENTA Stock
- Financials Fermenta Biotech Limited